Cite

HARVARD Citation

    Franco, D. et al. (2020). Proactive Versus Reactive Therapeutic Drug Monitoring of Infliximab in Crohn's Disease: Is the Juice Worth the Squeeze?. Inflammatory bowel diseases. 26 (1), pp. 112-113. [Online]. 
  
Back to record